Cohen-Boulakia F, Valensi P E, Boulahdour H, Lestrade R, Dufour-Lamartinie J F, Hort-Legrand C, Behar A
Laboratory of Biophysics, Paris 6 University, France.
Metabolism. 2000 Jul;49(7):880-5. doi: 10.1053/meta.2000.6754.
Alterations in the capillary filtration of macromolecules are well documented in diabetic patients and experimental diabetes. Various flavonoids including anthocyanosides and ginkgo biloba extracts have been shown to be effective against experimentally induced capillary hyperfiltration. The aim of the present study was to test the effects of anthocyanosides on capillary filtration in diabetic rats. For this purpose, we have validated the use of our previously described in vivo method for measurement of the capillary filtration of albumin (CFA) in rats. Male Wistar rats with streptozotocin (STZ)-induced diabetes were randomized in 3 groups to receive either ginkgo biloba (group A), Vaccinium myrtillus (group B), or no treatment (group C). The isotopic test of CFA consisted of intravenously injecting 99mtechnetium-labeled albumin, inducing venous compression on a hindquarter, and measuring radioactivity externally on the limb before, during, and after removal of venous compression. After removal of the tourniquet, the radioactivity curve decreased. Interstitial albumin retention (AR) and the ratio of the amplitudes of the low- and high-frequency peaks (LF/HF ratio), an index of lymphatic function obtained by the fast Fourier transform of the last part of the radioactivity curve, were calculated. In STZ-treated animals, the isotopic test was performed at a mean age of 97 days (time 1) and after 6 weeks (time 2) and 12 weeks (time 3) of treatment, ie, 6 and 12 weeks after time 1. At time 1, AR was significantly higher in the 3 diabetic groups than in the control rats, without a significant difference between these groups. In group B, AR decreased significantly (P = .015) at times 2 and 3. In group C, AR increased significantly (P < .0005) from time 1 to time 3. In group A, AR increased slightly (NS) between time 1 and time 3. In groups A and C, the LF/HF ratio significantly increased with time (P < .0005) and the levels at time 3 were significantly higher versus control rats (P < .0001). In group B, the LF/HF ratio remained unchanged from time 1 to time 3 and similar to the values found in the control rats. In conclusion, these data show that (1) this new in vivo noninvasive method can be used to study CFA in skeletal muscle in diabetic rats, (2) it is reproducible and may be repeated over several months to evaluate spontaneous microcirculatory changes, and (3) anthocyanosides appear to be effective in preventing the increase in CFA and the failure of lymphatic uptake of interstitial albumin in diabetic animals.
糖尿病患者和实验性糖尿病中,大分子物质的毛细血管滤过改变已有充分记录。包括花色苷和银杏叶提取物在内的多种类黄酮已被证明可有效对抗实验诱导的毛细血管超滤。本研究的目的是测试花色苷对糖尿病大鼠毛细血管滤过的影响。为此,我们验证了先前描述的用于测量大鼠白蛋白毛细血管滤过(CFA)的体内方法的实用性。将链脲佐菌素(STZ)诱导糖尿病的雄性Wistar大鼠随机分为3组,分别接受银杏叶(A组)、欧洲越橘(B组)或不治疗(C组)。CFA的同位素检测包括静脉注射99m锝标记的白蛋白,在后肢施加静脉压迫,并在去除静脉压迫之前、期间和之后在肢体外部测量放射性。去除止血带后,放射性曲线下降。计算间质白蛋白潴留(AR)以及通过放射性曲线最后部分的快速傅里叶变换获得的淋巴功能指标低频和高频峰振幅之比(LF/HF比)。在STZ处理的动物中,同位素检测在平均97天龄(时间1)时进行,并在治疗6周(时间2)和12周(时间3)后进行,即时间1后的6周和12周。在时间1时,3个糖尿病组的AR显著高于对照大鼠,这些组之间无显著差异。在B组中,AR在时间2和3时显著降低(P = 0.015)。在C组中,AR从时间1到时间3显著增加(P < 0.0005)。在A组中,AR在时间1和时间3之间略有增加(无统计学意义)。在A组和C组中,LF/HF比随时间显著增加(P < 0.0005),时间3时的水平显著高于对照大鼠(P < 0.0001)。在B组中,LF/HF比从时间1到时间3保持不变,与对照大鼠中的值相似。总之,这些数据表明:(1)这种新的体内非侵入性方法可用于研究糖尿病大鼠骨骼肌中的CFA;(2)它具有可重复性,可在几个月内重复进行以评估自发的微循环变化;(3)花色苷似乎可有效预防糖尿病动物中CFA的增加以及间质白蛋白淋巴摄取功能的衰竭。